Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis

NCT00070759 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

NIH

Sponsor class

Conditions

Uveitis

Interventions

DRUG: Daclizumab

Sponsor

National Eye Institute (NEI)